MSH|^~\&|SendAppName^2.16.840.1.114222.nnnn^ISO|Sending-Facility^2.16.840.1.114222.nnnn^ISO|PHINCDS^2.16.840.1.114222.4.3.2.10^ISO|PHIN^2.16.840.1.114222^ISO|20141225120030.1234-0500||ORU^R01^ORU_R01|STD_V1_CN_TM_TC05|T|2.5.1|||||||||NOTF_ORU_v3.0^PHINProfileID^2.16.840.1.114222.4.10.3^ISO~Generic_MMG_V2.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISO~STD_MMG_V1.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISOPID|1||STD_TC05^^^SendAppName&2.16.840.1.114222.GENv2&ISO||~^^^^^^S||19940302|F||2054-5^Black or African American^CDCREC|^^^51^23218^^^^51159^030500|||||||||||2186-5^Not Hispanic or Latino^CDCRECOBR|1||STD_TC05^SendAppName^2.16.840.1.114222.nnnn^ISO|68991-9^Epidemiologic Information^LN|||20140120170100|||||||||||||||20140120170100|||F||||||10280^Gonorrhea^NNDOBX|1|CWE|78746-5^Country of Birth^LN||GRC^Greece^ISO3166_1||||||FOBX|2|CWE|77983-5^Country of Usual Residence^LN||USA^United States^ISO3166_1||||||FOBX|3|TS|11368-8^Date of Illness Onset^LN||20140115||||||FOBX|4|TS|77976-9^Illness End Date^LN||20140127||||||FOBX|5|SN|77977-7^Illness Duration^LN||^12|d^day^UCUM|||||FOBX|6|CWE|77996-7^Pregnancy Status^LN||N^No^HL70136||||||FOBX|7|TS|77975-1^Diagnosis Date^LN||20140117||||||FOBX|8|CWE|77974-4^Hospitalized^LN||Y^Yes^HL70136||||||FOBX|9|TS|8656-1^Admission Date^LN||20140118||||||FOBX|10|TS|8649-6^Discharge Date^LN||20140127||||||FOBX|11|SN|78033-8^Duration of Hospital Stay in Days^LN||^9||||||FOBX|12|CWE|77978-5^Subject Died^LN||N^No^HL70136||||||FOBX|13|ST|77993-4^State Case Identifier^LN||2014LEV100000001||||||FOBX|14|ST|77997-5^Legacy Case Identifier^LN||<use state-assigned value>||||||FOBX|15|SN|77998-3^Age at Case Investigation^LN||^19|a^year^UCUM|||||FOBX|16|CWE|77982-7^Case Disease Imported Code^LN||C1512888^International^UMLS||||||FOBX|17|CWE|INV153^Imported Country^PHINQUESTION||MEX^Mexico^ISO3166_1||||||FOBX|18|CWE|77984-3^Country of Exposure^LN|1|MEX^Mexico^ISO3166_1||||||FOBX|19|CWE|77985-0^State or Province of Exposure^LN|1|MX-GRO^Guerrero^ISO3166_2||||||FOBX|20|CWE|77989-2^Transmission Mode^LN||417564009^Sexual transmission^SCT||||||FOBX|21|CWE|77990-0^Case Class Status Code^LN||410605003^Confirmed present^SCT||||||FOBX|22|CWE|77965-2^Immediate National Notifiable Condition^LN||N^No^HL70136||||||FOBX|23|CWE|77980-1^Case Outbreak Indicator^LN||N^No^HL70136||||||FOBX|24|ST|77969-4^Jurisdiction Code^LN||S01||||||FOBX|25|CWE|48766-0^Reporting Source Type Code^LN||1^Hospital^HL70406||||||FOBX|26|ST|52831-5^Reporting Source Zip Code^LN||23218||||||FOBX|27|ST|77988-4^Binational Reporting Criteria^LN||PHC1139^Has case contacts from Mexico or Canada^CDCPHINVS||||||FOBX|28|ST|74549-7^Person Reporting to CDC-Name^LN||Green, Marta||||||FOBX|29|ST|74548-9^Person Reporting to CDC-Phone Number^LN||(877)721-7725||||||FOBX|30|ST|74547-1^Person Reporting to CDC-Email^LN||Green@you.com||||||FOBX|31|DT|77979-3^Case Investigation Start Date^LN||20140117||||||FOBX|32|DT|77995-9^Date Reported^LN||20140117||||||FOBX|33|TS|77972-8^Earliest Date Reported to County^LN||20140117||||||FOBX|34|TS|77973-6^Earliest Date Reported to State^LN||20140117||||||FOBX|35|SN|77991-8^MMWR Week^LN||^4||||||FOBX|36|DT|77992-6^MMWR Year^LN||2014||||||FOBX|37|DT|77994-2^Date CDC Was First Verbally Notified of This Case^LN||20140117||||||FOBX|38|DT|77970-2^Date First Reported to PHD^LN||20140117||||||FOBX|39|CWE|77966-0^Reporting State^LN||51^Virginia^FIPS5_2||||||FOBX|40|CWE|77967-8^Reporting County^LN||51159^Richmond^FIPS6_4||||||FOBX|41|CWE|77968-6^National Reporting Jurisdiction^LN||51^Virginia^FIPS5_2||||||FOBX|42|TX|77999-1^Comment^LN||<use any comment>||||||FOBX|43|CWE|76691-5^Gender Identity^LN||PHC1490^Cisgender/Not transgender (finding)^CDCPHINVS||||||FOBX|44|CWE|76690-7^Sexual Orientation^LN||20430005^Heterosexual^SCT||||||FOBX|45|DT|STD099^Date of Initial Health Exam Associated with Case Report "Health Event"^PHINQUESTION||20140117||||||FOBX|46|DT|STD105^Treatment Date^PHINQUESTION||20140117||||||FOBX|47|CWE|55277-8^HIV Status^LN||165816005^HIV positive^SCT||||||FOBX|48|CWE|STD107^Had Sex with a Male within the Past 12 Months^PHINQUESTION||Y^Yes^HL70136||||||FOBX|49|CWE|STD108^Had Sex with a Female within the Past 12 Months^PHINQUESTION||NASK^Did Not Ask^NULLFL||||||FOBX|50|CWE|STD109^Had Sex with an Anonymous Partner within the Past 12 Months^PHINQUESTION||Y^Yes^HL70136||||||FOBX|51|CWE|STD110^Had Sex with a Person Known to Him/Her to be an "Intravenous Drug User (IDU)" within the Past 12 months^PHINQUESTION||NASK^Did Not Ask^NULLFL||||||FOBX|52|CWE|STD111^Had Sex while Intoxicated and/or High on Drugs within the Past 12 months^PHINQUESTION||N^No^HL70136||||||FOBX|53|CWE|STD112^Exchanged Drugs/Money for Sex within the Past 12 Months^PHINQUESTION||Y^Yes^HL70136||||||FOBX|54|CWE|STD113^Had Sex with a Person Who is Known to Her to Be an MSM within Past 12 Months^PHINQUESTION||Y^Yes^HL70136||||||FOBX|55|CWE|STD114^Engaged in Injection Drug use Within Past 12 Months?^PHINQUESTION||N^No^HL70136||||||FOBX|56|CWE|INV159^Detection Method^PHINQUESTION||306098008^Self-referral^SCT||||||FOBX|57|CWE|STD117^Previous STD History^PHINQUESTION||N^No^HL70136||||||FOBX|58|CWE|STD118^Been Incarcerated within the Past 12 Months^PHINQUESTION||NASK^Did Not Ask^NULLFL||||||FOBX|59|CWE|STD119^Have You Met Sex Partners through the Internet in the Last 12 Months^PHINQUESTION||Y^Yes^HL70136||||||FOBX|60|SN|STD120^Total Number of Sex Partners in the Last 12 months^PHINQUESTION||^2||||||FOBX|61|CWE|STD999^Unknown Number of Sex Partners in Last 12 Months^PHINQUESTION||N^No^HL70136||||||FOBX|62|CWE|INV892^HIV Status Documented Through eHARS Record Search^PHINQUESTION||UNK^Unknown^NULLFL||||||FOBX|63|CWE|INV895^Case Sampled for Enhanced Investigation^PHINQUESTION||N^No^HL70136||||||FOBX|64|CWE|INV290^Test Type^PHINQUESTION|2|698-1^N gonorrhea XXX QI Cult^LN||||||FOBX|65|CWE|INV291^Test Result^PHINQUESTION|2|10828004^Positive (qualifier value)^SCT||||||FOBX|66|DT|82772-5^Date of lab result^LN|2|20140226||||||FOBX|67|CWE|31208-2^Specimen source^LN|2|76784001^vaginal structure^SCT||||||FOBX|68|DT|33882-2^Specimen Collection Date^LN|2|20140225||||||FOBX|69|CWE|LABAST1^Microorganism Identified in Isolate^PHINQUESTION|3|68704007^Neisseria gonorrhea (organism)^SCT||||||FOBX|70|ST|LABAST2^Isolate Identifier^PHINQUESTION|3|SLT-12466||||||FOBX|71|CWE|LABAST3^Antimicrobial Susceptibility Specimen Type^PHINQUESTION|3|119394009^Specimen from vagina (specimen)^SCT||||||FOBX|72|CWE|LABAST4^Antimicrobial Specimen Collection Site^PHINQUESTION|3|76784001^Vaginal structure (body structure)^SCT||||||FOBX|73|DT|LABAST5^Antimicrobial Susceptibility Specimen Collection Date^PHINQUESTION|3|20140226||||||FOBX|74|CWE|LABAST6^Antimicrobial Susceptibility Test Type^PHINQUESTION|3|18866-4^Azithromycin Susc Islt^LN||||||FOBX|75|CWE|LABAST7^Antimicrobial Susceptibility Test Method^PHINQUESTION|3|104234003^Gradient strip susceptibility test (procedure)^SCT||||||FOBX|76|CWE|LABAST8^Antimicrobial Susceptibility Test Interpretation^PHINQUESTION|3|30714006^Resistant (qualifier value)^SCT||||||FOBX|77|ST|LABAST9^Antimicrobial Susceptibility Test Result Quantitative Value^PHINQUESTION|3|>64.0||||||FOBX|78|CWE|LABAST10^Antimicrobial Susceptibility Test Result Numerical Value Units^PHINQUESTION|3|ug/ml^microgram per mililiter^UCUM||||||FOBX|79|CWE|LABAST11^Antimicrobial Susceptibility Test Result Coded Quantitative^PHINQUESTION|3|MIC64^64.0^CDCPHINVS||||||FOBR|2|GON23456-1^EHR^2.16.840.1.113883.19.3.2.3^ISO|GON9700123-1^Lab^2.16.840.1.113883.19.3.1.6^ISO|698-1^N gonorrhea XXX QI Cult^LN|||20140120170100|||||||||121121121^^^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD||||||20140120170100|||F||||||O9822^Gonorrhea complicating pregnancy^I10COBX|1|CWE|698-1^N gonorrhea XXX QI Cult^LN|1|68704007^Neisseria gonorrhea^SCT||||||F|||20140117|||0001^Complement fixation^OBSMETHOD||20140117||||GHH Lab^L^^^^CLIA&2.16.840.1.113883.19.4.6&ISO^XX^^^1236||9876543^^^^^^^^NPI&1.3.6.1.4.1.562.2.4.1.43&ISO^^^^NPIOBX|2|CX|80398-1^Unique identifier for Current sample^LN||8587924616||||||FNTE|1|L|Titers > or = 1:8 suggest either gonococcal infection or asymptomatic colonization. Antibodies recognizing Neisseria gonorrhoeae are apparently unprotective, since reinfection frequently occurs.SPM|1|GON23456-1&EHR&2.16.840.1.113883.19.3.2.3&ISO^GON9700122-1&Lab&2.16.840.1.113883.19.3.1.6&ISO||119364003^Serum specimen^SCT||||368149001^Right Elbow^SCT|||P^Patient^HL70369|2^mL&milliliter&UCUM||Serum Sample|||20140117|20140117OBR|3||GON9700123-1^Lab^2.16.840.1.113883.19.3.1.6^ISO|50545-3^Bacterial susceptibility panel by Minimum inhibitory concentration (MIC)^LN|||20140120170100||||G||||||||||||||F|698-1^N gonorrhea XXX QI Cult^LN|||GON23456-1&EHR&2.16.840.1.113883.19.3.2.3&ISOOBX|1|SN|267-5^Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)^LN|1|^2.0|ug/mL^MicroGrams Per MiliLiter^UCUM|||||F